
| A | B | C | D | E | |
| Base No. (GRCh38.p14) | OR (95% CI) | Original p-value | Adjusted p-value | Gene Name | |
| 1860203 | 5.58 (2.76–11.31) | < .000 | < .000 | CACNA2D4 | |
| 4628152 | 5.43 (2.43–12.11) | < .000 | < .000 | AKAP3 | |
| 11869533 | 5.94 (2.93–12.05) | < .000 | < .000 | ETV6 | |
| 13537468 | 5.25 (2.97–9.27) | < .000 | < .000 | GRIN2B | |
| 30983164 | 5.53 (2.60–11.76) | < .000 | < .000 | TSPAN11 | |
| 38321345 | 5.77 (2.85–11.69) | < .000 | < .000 | ALG10B | |
| 40340400 (G2019S) | 5.46 (2.90–10.27) | < .000 | < .000 | LRRK2 (PARK8) | |
| 48569196 | 5.28 (2.61–10.70) | < .000 | < .000 | LALBA | |
| 49990203 | 5.09 (2.26–11.48) | < .000 | .002 | RACGAP1 | |
| 52107506 | 5.33 (2.36–12.02) | < .000 | .001 | SMIM41 | |
| 65955867 | 5.06 (2.24–11.42) | < .000 | .002 | HMGA2 | |
| 66254622 | 5.87 (2.89–11.89) | < .000 | < .000 | IRAK3 | |
| 81260048 | 5.30 (2.35–11.96) | < .000 | .001 | ACSS3 | |
| 108544453 | 5.01 (2.48–10.15) | < .000 | < .000 | SART3 | |
| 120460300 | 5.69 (2.67–12.10) | < .000 | < .000 | GATC |
| A | B | C | D | |
| Association | ||||
| Gene Name | Role of Gene | Neurodegeneration or Brain Disorders | PD | |
| CACNA2D4 | Encodes a protein in the voltage-dependent calcium channel complex [3] | ADHD or bipolar disorder [4] | Unclear | |
| AKAP3 | Encodes functionally related proteins that target protein kinase A to specific locations within cells [5] | AD, seizure, mental retardation and drug addiction [6] | Unclear | |
| ETV6 | Encodes an erythroblast transformation-specific family transcription factor [7] | Associated with adult hematopoietic stem cells [8] | Associated with β-synuclein rearrangement which has a similar structure to α-syn [9] | |
| GRIN2B | Encodes a member of the N-methyl-D- aspartate receptor family [10] | Intellectual disability, developmental delays, autism spectrum disorder, and AD [11] | May be associated with the phenotype of PD such as how or when PD occurs [12] | |
| TSPAN11 | Contributes determination of bone matrix organization direction [13] | The dysfunction of TSPAN6 is associated with AD [14] | Unclear | |
| ALG10B | Involves a dolichol-linked oligosaccharide biosynthetic process [15] | Dysfunction exacerbates neurodegeneration [16] | Unclear | |
| LALBA | Encodes the alpha-lactalbumin protein of milk [17] | Unclear | Unclear | |
| BACGAP1 | Associated with roles of cytokinesis, cell growth, and differentiation [18] | Since the protein coded by RACGAP1 plays a part of roles in apoptosis, it may be connected with neurodegenerative disorders. | Unclear | |
| SMM41 | Not been studied very well. | Unclear | Unclear | |
| HMGA2 | Encodes a protein that functions as an architectural factor of the enhanceosome [19] | In mice experiments, AD mice treated by silencing HMGA2 had improved learning and memory ability, alleviated brain injury, and decreased inflammatory and oxidative stress reactions. [20] | Unclear | |
| IRAK3 | Mutations are associated with a susceptibility to asthma [21] | In mice, IRAK3 deficiency exacerbates dopaminergic neuron damage in PD [22] | ||
| ACSS3 | Located in the mitochondrial matrix and is predicted to be involved in the ketone body biosynthetic process [23] | AD [24] | Unclear | |
| SART3 | Encodes an RNA-binding nuclear protein that may contribute to tumor rejection and specific immunotherapy [25] | Bi-allelic variants in SART3 are associated with a syndrome characterized by developmental delay [26] | Unclear | |
| GATC | May have a role in ATP binding activity and glutaminyl-tRNA synthase activity [27] | Unclear | Unclear | |